✔ Powered by Niacinamide – minimize enlarged pores and refine skin texture
✔ Enriched with White Lotus – purify, soothe and refine skin texture with gentle botanicals
✔ Zero White Cast, Non-Greasy & Ultra-Lightweight Finish
✔ Net Quantity: 50ML
✔ Suitable for All Skin Types
✔ 100% Vegan, Cruelty-Free & Toxin-Free
✔ FDA Approved & Dermatologically Tested
Chat with us and get quick help before placing your order.
| Brand | Pilgrim |
|---|---|
| Product Name | Korean White Lotus Tinted Sunscreen SPF 50+ PA++++ With 3% Niacinamide |
| Product Type | simple |
| Net Quantity | 50ML |
| Key Ingredients | Niacinamide & White Lotus |
| Skin Type | All Skin Types |
| Key Benefits | Dermatologically Tested, 100% Vegan |
| Texture | Lightweight Emulsion |
| Special Feature | 100% Vegan, Cruelty-Free, Toxin-Free |
| Suitable For | All Skin Types |
| Application Area | Face & Body |
| Recommended Usage | Daily |
| Formula Type | Lightweight Emulsion |
| Comedogenic | Non-comedogenic |
Elevate your sunscreen routine with Pilgrim Korean White Lotus Tinted Sunscreen SPF 50+ PA++++ With 3% Niacinamide. Crafted by Pilgrim using globally sourced, nature-backed ingredients and cutting-edge cosmetic science, this product delivers real, visible results while remaining exceptionally gentle on your skin.
Offering high-level broad-spectrum defense against UVA and UVB rays, this Pilgrim sunscreen shields against photodamage, sunburn, and premature fine lines. Its lightweight, zero-white-cast formula absorbs effortlessly, making it ideal for daily wear under makeup or on bare skin.
Dermatologically tested and certified safe for all skin types. 100% Vegan, Cruelty-Free, and formulated without sulfates, parabens, mineral oils, or harmful chemical additives.
Net Quantity: 50ML
Apply generously to face, neck, and any exposed skin 15-20 minutes prior to sun exposure as the final step of your skincare routine. Use approximately two finger-lengths for face and neck. Reapply every 2-3 hours during prolonged sun exposure, swimming, or sweating.
No reviews yet.
